The role of the melanocortin-3 receptor in cachexia

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 258-266

  Marks, Daniel L ^a   Cone, Roger D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Appetite; Cachexia; Cancer; Melanocortin; Proopiomelanocortin

Indexed keywords

MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN;

ACUTE DISEASE; APPETITE; BODY MASS; CACHEXIA; CANCER; CHRONIC DISEASE; CONFERENCE PAPER; DRUG USE; ENDOCRINE SYSTEM; EXPERIMENTAL MODEL; HUMAN; HYPOTHALAMUS; KNOCKOUT MOUSE; LIPID METABOLISM; MELANOCORTIN SYSTEM; NONHUMAN; RECEPTOR BLOCKING;

EID: 0038389377     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03188.x     Document Type: Conference Paper

References (40)

1. KATZ, A.M. & P.B. KATZ. 1962. Diseases of the heart in the works of Hippokrates. Br. Heart J. 24: 257-264.
2. TISDALE, M.J. 1997. Biology of cachexia. J. Natl. Cancer Inst. 89: 1763-1773.
3. LARKIN, M. 1998. Thwarting the dwindling progression of cachexia. Lancet 351: 1336.
4. KOTLER, D.P. et al. 1989. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am. J. Clin. Nutr. 50: 444-447.
5. PLATA-SALAMAN, C.R. 1989. Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems. Br. Behav. Immun. 3: 193-213.
6. PLATA-SALAMAN, C.R. 1998. Brain mechanisms in cytokine-induced anorexia. Psychoneuroendocrinology 24: 25-41.
7. INUI, A. 1999. Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci. 22: 62-67.
8. JEGOU, S. et al. 2000. Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J. Neuroendocrinol. 12: 501-505.
9. MOUNTJOY, K.G. & J.M. WILD. 1998. Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Dev. Brain. Res. 107: 309-314.
10. XIA, Y. & J.E.S. WIKBERG. 1997. Postnatal expression of melanocortin-3 receptor in rat diencephalon and mesencephalon. Neuropharmacology 36: 217-224.
11. HASKELL-LUEVANO, C. et al. 1999. Characterization of the neuroanatomical distribution of agouti-related protein (AGRP) immunoreactivity in the rhesus monkey and the rat. Endocrinology 140: 1408-1415.
12. FAN, W. et al. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168.
13. MARKS, D.L., N. LING & R.D. CONE. 2001. Role of the central melanocortin system in cachexia. Cancer Res. 61: 1432-1438.
14. MARKS, D.L. & R.D. CONE. 2001. Central melanocortins and the regulation of weight during acute and chronic disease. Recent Prog. Horm. Res. 56: 359-375.
15. HILLHOUSE, E.W. & K. MOSLEY. 1993. Peripheral endotoxin induces hypothalamic immunoreactive interleukin-1 beta in the rat. Br. J. Pharmacol. 109: 289-290.
16. VAN DAM, A.M. et al. 1995. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65: 815-826.
17. CAVAILLON, J.M. & N. HAEFFNER-CAVAILLON. 1990. Signals involved in interleukin-1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine 2: 313-329.
18. MOLLOY, R.G., J.A. MANNICK & M.L. RODRICK. 1993. Cytokines, sepsis and immuno-modulation. Br. J. Surg. 80: 289-297.
19. TATRO, J.B. et al. 1999. Role of the melanocortin-4 receptor in thermoregulatory responses to central IL-1β. Soc. Neurosci. Abstr. 25: 1558.
20. HUANG, Q.H., V.J, HRUBY & J.B. TATRO. 1999. Role of central melanocortins in endotoxin-induced anorexia. Am. J. Physiol. 276: R864-R871.
21. SVANINGER, G., C. DROTT & K. LUNDHOLM. 1987. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting. J. Natl. Cancer Inst. 78: 943-950.
22. EMERY, P.W. 1999. Cachexia in experimental models. Nutrition 15: 600-603.
23. EMERY, P.W., L. LOVELL & M.J. RENNIE. 1984. Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice. Cancer Res. 44: 2779-2784.
24. SVANINGER, G., J. GELIN & K. LUNDHOLM. 1989. The cause of death in non-metastasizing sarcoma bearing mice. Eur. J. Cancer Clin. Oncol. 25: 1295-1302.
25. SIMONS, J.P. et al. 1998. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial. Cancer 82: 553-560.
26. SIMONS, J.P. et al. 1999. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin. Sci. (London) 97: 215-223.
27. BUTLER, A.A. et al. 2000. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141: 3518-3521.
28. CHEN, A.S. et al. 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26: 97-102.
29. BAGNOL, T. et al. 1999. The anatomy of an endogenous antagonist: relationship between agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19: RC26.
30. BUTLER, A.A. et al. 2001. Melanocortin-4 receptor is required for adaptive thermogenesis and behavioral responses to increased dietary fat. Nat. Neurosci. 4(6): 605-611.
31. ROSELLI-REHFUSS, L. et al. 1993. Identification of a receptor for γ-MSH and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. USA 90: 8856-8860.
32. CHHAJLANI, V. 1996. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38: 73-80.
33. GETTING, S.J. et al. 1999. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162: 7446-7453.
34. GETTING, S.J., R.J. FLOWER & M. PERRETTI. 1999. Agonism at melanocortin receptor type 3 on macrophages inhibits neutrophil influx. Inflamm. Res. 48(Suppl. 2): S140-S141.
35. MARKS, D.L. et al. 2003. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 144(4): 1513-1523.
36. LAWRENCE, C.B. & N.J. ROTHWELL. 2001. Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J. Neuroendocrinol. 13: 490-495.
37. WISSE, B.E. et al. 2001. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 142: 3292-3301.
38. KLEBIG, M.L. et al. 1995. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc. Natl. Acad. Sci. USA 92: 4728-4732.
39. OLLMANN, M.M. et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138.
40. YEN, T.T. et al. 1994. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J. 8: 479-488.